Indolent/Low Grade Non-Hodgkin’s Lymphoma


Two Different Approaches to Rituxan Both Effective For Follicular Lymphoma (02-10-2012)

Among patients with low-tumor-burden follicular lymphoma who have received initial treatment with Rituxan® (rituximab), waiting until disease progression to take additional Rituxan is as effective as ongoing, maintenance Rituxan. These results were presented... Continue Reading

Addition of Zevalin® to Chemotherapy Effective for Follicular NHL (11-10-2008)

Addition of Zevalin® to Chemotherapy Effective for Follicular NHL Administration of Zevalin® (Y-ibritumomab tiuxetan) immediately following initial chemotherapy for advanced follicular lymphoma improves progression-free survival for two years compared... Continue Reading

Survival Rates Improving in Childhood Hematologic Cancers (09-29-2008)

Survival Rates Improving in Childhood Hematologic Cancers Five- and 10-year survival rates in childhood hematalogic cancers have significantly improved since 1990, according to the results of a study recently published in the Journal of the National Cancer... Continue Reading